All lobbying filings

TARPLIN, DOWNS & YOUNG, LLC

TARPLIN, DOWNS & YOUNG, LLC filed a Q3 report for BRISTOL MYERS SQUIBB on October 20, 2026, reporting $80,000 in lobbying income.

Lobbying for BRISTOL MYERS SQUIBB · Global biopharma company developing innovative medicines

All filings by TARPLIN, DOWNS & YOUNG, LLC · Everything BRISTOL MYERS SQUIBB has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$80,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 5

RAISSA H DOWNS

Previously held: Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
JENNIFER B YOUNG

Previously held: Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance
EMILY H MURRY

Previously held: Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price
PETER FISE

Previously held: Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform
PARICK BRAERTON CARROLL

Previously held: Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medicare/Medicaid

Medicare & Medicaid payment and coverage issues

Health Issues

Lobbying related to pharmaceutical policy

Budget/Appropriations

federal budget issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.